Focuses on increased AI technology and client wins in Asia, Middle East The Telerad Group, a leading global provider of remote radiology services today announced a significant growth outlook of 50% for the upcoming financial year aiming to continue the momentum from last year’s (2022-23) 40%
Marking a major step in the global expansion strategy of Venus Remedies through its oncology products, this marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA regions In a decisive step towards making its
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans Venus Remedies Limited, a leading research-based pharmaceutical company, has achieved another significant milestone by securing a Good Manufacturing Practices (GMP) certification from
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from Philippines for bleomycin, a widely used cancer drug Venus Remedies also expects the marketing authorisation
Rezo.ai is virtually assisting over 10 million patients while cutting down the service provider’s operational costs by 20-30% New Delhi, November XX, 2021: Rezo.ai, India’s fastest evolving AI-powered contact center, is assisting one of India’s largest diagnostic and healthcare service providers with contact center automation.
